Howard Hechler

Howard Hechler joined Lumicell in August of 2020 and brings to the company more than 15 years of focused life-sciences experience in M&A, strategy, and operations. His background spans a wide range of medical devices, diagnostics, pharmaceuticals, and drug-device combination products. Over his career, he has been involved in more than $500M in strategic transactions, as well as leading cross-functional teams to develop business cases and C-Suite strategic plans. Prior to joining Lumicell, Howard worked at Locust Walk, a boutique life sciences investment bank, where he used his background and experience to support the growth and extend the reach of the firm’s medical technology practice. Before joining Locust Walk, Howard served as Chief Business Officer for PolarityTE, a regenerative medicine company, where he was responsible for business development, marketing, sales, and market access/reimbursement strategies. Howard also worked in Business Development for Mallinckrodt Pharmaceuticals (a subsidiary of Coviden at the time), where he closed multiple co-promotions, financings, and divestitures. Howard then spent five years at Medtronic, running business development for the Surgical Technologies Business Unit ($2B in sales) and leading a broad range of acquisitions, divestitures, licenses, distribution deals, and equity investments. Howard graduated cum laude with an AB in Near Eastern Language and Civilizations from Harvard University. He received both his Master of Business Administration and Juris Doctorate from the University of Virginia.